ArticleBMJ open2019

Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial.

Michael Cole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.